Immunome Inc
IMNMHealthcare|Biotechnology|USA
$23.35
-0.82 (-3.39%)
Tangible Book
$5.20
About
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
Stock Price
+160.9%(1Y)
Pipeline Summary
10 total trials8
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
Completed: 4Recruiting: 4Active: 1Terminated: 1
Active Trials (5)
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
NCT06823167Solid Malignancies
Phase 1Recruiting
Enrollment: 117 participants
A Study of AL102 in Patients With Progressing Desmoid Tumors
NCT04871282Desmoid
Phase 2Phase 3Active
Enrollment: 198 participants
A Relative Bioavailability and Bioequivalence Study of Varegacestat in Healthy Participants
NCT07610005Healthy
Phase 1Recruiting
Enrollment: 20 participants
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
NCT07578571Colorectal Cancer
Phase 1Recruiting
Enrollment: 175 participants
A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer
NCT07505771Solid Malignancies
Early P1Recruiting
Enrollment: 105 participants
BioScore
5.6/10
Watchlist
Ownership
Recent Insider Trades
Horn KinneySELL
2026-07-071,092 shares @ $25
Barchas IsaacSELL
2026-07-07100,000 shares @ $24.13
Lechleider RobertSELL
2026-07-0255,000 shares @ $22.62
Barchas IsaacSELL
2026-07-02201,050 shares @ $21.85
Lechleider RobertSELL
2026-06-2555,000 shares @ $19.85
Recent News
2026-07-08 14:55:32
2026-07-08 12:00:09
2026-07-08 11:52:09
2026-07-07 21:00:14
Data last updated: Jul 13, 2026, 12:42 PM